Skip to main content

Year: 2021

Rezolute Reports First Quarter Fiscal 2022 Financial Results and Highlights Recent Company Progress

REDWOOD CITY, Calif., Nov. 12, 2021 (GLOBE NEWSWIRE) — Rezolute, Inc. (Nasdaq: RZLT), a clinical-stage biopharmaceutical company developing transformative therapies for metabolic diseases associated with chronic glucose imbalance, today announced its financial results for the first quarter of fiscal 2022 ended September 30, 2021. “This has been a productive quarter of execution for Rezolute, with steady clinical advancement of our lead pipeline candidates, RZ358 and RZ402, in Phase 2b and Phase 1b development, respectively,” said Nevan Elam, Chief Executive Officer and Founder of Rezolute. “We look forward to announcing topline data for both programs in Q1 of 2022. Additionally, with a strengthened balance sheet following our recent offering, raising $55 million in gross proceeds, we have extended our cash runway and are well-positioned...

Continue reading

Usio to Participate in the Ladenburg Thalmann Virtual Technology Expo on November 18th

Presentation on Thursday, November 18, 2021, at 11:30AM ET SAN ANTONIO, Nov. 12, 2021 (GLOBE NEWSWIRE) — Usio, Inc. (Nasdaq: USIO), a leading FinTech integrated payment solutions provider, today announced it will participate in the Ladenburg Thalmann Virtual Technology Expo taking place November 18, 2021. Louis Hoch, Chief Executive Officer, Greg Carter, Senior Vice President, Payment Facilitation, and Houston Frost, Senior Vice President, Prepaid Services, will conduct one-on-one meetings with investors. For more information on the conference or to register, visit: https://ladenburg21.mysequire.com/. Investors can also request one-on-one meetings with Usio on the event website. The Company will present on Thursday, November 18, 2021, at 11:30 a.m. ET. The event will also be available on the Usio website at https://usio.com/investors/ About...

Continue reading

Millicom (Tigo) closes Guatemala transaction

Millicom (Tigo) closes Guatemala transaction Luxembourg, November 12, 2021 – Millicom announced today that it has closed the previously-announced agreement to acquire the remaining 45% equity interest in its joint venture businesses in Guatemala. For further information, please contactPress:Vivian Kobeh, Director Corporate Communications +1-786-628-5300press@millicom.com   Yocasta Valdez, Group Manager Digital Media & Communications+1-305-929-5417press@millicom.com Investors:Michel Morin, VP Investor Relations+1-786-628-5270investors@millicom.com   Sarah Inmon, Director Investor Relations+1-786-628-5303investors@millicom.comAbout Millicom Millicom (NASDAQ U.S.: TIGO, Nasdaq Stockholm: TIGO_SDB) is a leading provider of fixed and mobile services dedicated to emerging markets in Latin America...

Continue reading

IDEX Biometrics: Subscription Rights Exercise – 12 Nov 2021

The board of directors of IDEX Biometrics ASA has resolved to issue in total 1,103,442 ordinary shares at average price NOK 1.65 per share to employees who have exercised incentive subscription rights. The incentive subscription rights were issued under the company’s 2019 and 2020 incentive subscription rights plans, which plans were approved by the annual general meeting on 9 May 2019 and 12 May 2020 respectively. The employees have paid the subscription amount to the company. Following the issue, the company’s share capital will be NOK 151,558,268.10 divided into 1,010,388,454 shares each with a nominal value of NOK 0.15. Following the exercise, there are 71.281.124 incentive subscription rights outstanding. For further information contact:Marianne Bøe, Investor RelationsE-mail: marianne.boe@idexbiometrics.comTel: + 47 918 00186 About...

Continue reading

Sorrento Therapeutics Mexico to Partner with the World Boxing Council for the Screening of COVID-19 of all Convention Attendees with COVI-STIX at the 59th World Boxing Council Convention in Mexico City

SAN DIEGO and MEXICO CITY, Nov. 12, 2021 (GLOBE NEWSWIRE) — Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”) and the World Boxing Council (“WBC”) announced today that Sorrento’s COVI-STIX COVID-19 Virus Rapid Antigen Detection Test (“COVI-STIX”) will be used for screening all attendees of the upcoming 59th World Boxing Council Annual Convention in Mexico City, Mexico (November 14th through November 18th). The pandemic brought the world to a standstill and while most sports froze, boxing remained active through efforts by promoters, boxing commissions and the WBC. Boxing leads the world of sports in administrative and medical protocols to allow boxing matches to be held in bubbles without fans present. Testing is and should remain a major factor for the successful organization of any public event, including boxing events with...

Continue reading

IBEX Limited to Announce First Quarter Fiscal Year 2022 Financial Results on November 22, 2021

WASHINGTON, Nov. 12, 2021 (GLOBE NEWSWIRE) — IBEX Limited (“ibex”) (Nasdaq: IBEX), a leading global provider of business process outsourcing (BPO) and customer engagement technology solutions, today announced that it will report first quarter fiscal year 2022 financial results after the market close on Monday, November 22, 2021. Management will host a conference call and webcast to discuss the Company’s financial results, recent developments and business outlook at 4:30 p.m. ET.What: ibex Limited Announces First Quarter Fiscal Year 2022 Financial ResultsWhen: Monday, November 22, 2021Time: 4:30 p.m. ETLive Call: US/Canada Toll-Free: (833) 614-1408International: (914) 987-7129Conference ID: 3885337Replay: US/Canada Toll-Free: (855) 859-2056International: (404) 537-3406Conference ID: 3885337(Available approximately...

Continue reading

Freddie Mac Prices $933 Million Multifamily K-Deal, K-746

MCLEAN, Va., Nov. 12, 2021 (GLOBE NEWSWIRE) — Freddie Mac (OTCQB: FMCC) recently priced a new offering of Structured Pass-Through Certificates (K Certificates), which are backed by underlying collateral consisting of fixed-rate multifamily mortgages with predominantly 7-year terms. The company expects to issue approximately $933 million in K Certificates (K-746 Certificates), which are expected to settle on or about November 18, 2021. K-746 PricingClass Principal/Notional Amount (mm) Weighted Average Life (Years) Spread (bps) Coupon Yield Dollar PriceA-1 $46.269 4.38 S+2 1.2310% 1.2157% $99.9962A-2 $731.826 6.80 S+15 2.0310% 1.5509% $102.9950A-M $155.000 Sold via WI-K746X1 $778.095 Non-OfferedXAM $155.000 Non-OfferedX3 $49.111 Non-Offered*For more information on Freddie Mac’s When-Issued K-Deal, WI-K746,...

Continue reading

DraftKings Sportsbook at Foxwoods Resort Casino Opens November 13

Guests will be able to enjoy the dynamic, fully integrated retail sportsbook that combines sports betting with dining, gaming and moreDraftKings Sportsbook at Foxwoods Resort CasinoDraftKings Sportsbook at Foxwoods Resort CasinoDraftKings Sportsbook at Foxwoods Resort CasinoDraftKings Sportsbook at Foxwoods Resort CasinoMASHANTUCKET, Conn. and BOSTON, Nov. 12, 2021 (GLOBE NEWSWIRE) — Sports fans, get ready to be at the center of it all. Foxwoods Resort Casino and DraftKings Inc. (Nasdaq: DKNG) today announced that the new DraftKings Sportsbook at Foxwoods will open on Saturday, November 13, 2021 at 9:30 a.m. The new space will replace the temporary location that premiered in September. This opening comes after the successful launch of online sports betting and iGaming in Connecticut. Located within...

Continue reading

Selectis Health Schedules Third Quarter Earnings Call for Tuesday, November 16, 2021

Greenwood Village, Colorado, Nov. 12, 2021 (GLOBE NEWSWIRE) — Selectis Health, Inc. (OTC: GBCS) (“Selectis” or the “Company”), announced today that it expects to issue its third quarter 2021 financial results on November 16, 2021. Conference Call Selectis invites current and prospective investors to join the shareholder call on November 16, 2021, at 4:15 PM EST (1:15 PM PST), during which Selectis’ management will discuss the Company’s third quarter 2021 performance. The number to call for the interactive teleconference is (877)-705-6003 and the confirmation number is 13725159. A telephonic replay of the call will be available after 7:15 PM EST on the same day through Tuesday, November 30, 2021, by dialing (844)-512-2921 and entering the confirmation number 13725159. About Selectis Health Selectis Health...

Continue reading

Groupe Casino – Nombre de droits de vote et d’actions au 31-10-2021

CASINO, GUICHARD-PERRACHON Société anonyme au capital de 165 892 131,90 €Siège social : 1, Cours Antoine Guichard42000 Saint-Etienne554 501 171 R.C.S. Saint-Etienne Informations relatives au nombre total de droits de voteet d’actions composant le capital socialau 31 octobre 2021 (article 223-16 du Règlement Général de l’Autorité des Marchés Financiers)Nombre d’actions composant le capital Nombre total de droits de vote Nombre total de droits de vote exerçables en assemblée générale108 426 230  146 264 271 145 831 656* * ** Fait le 12 novembre 2021 à 14h40AttachmentCasino – Nombre de droits de vote et d’actions au 31-10-2021 – Communiqué

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.